MedTrace Logo

Recovery With Tart Cherry Supplementation Following a Marathon.

NCT06332222 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-03-27

No results posted yet for this study

Summary

The goal of this clinical trial is to compare recovery in healthy, active runners.

The main questions it aimed to answer were whether 7 day supplementation with Vistula TC attenuated:

* muscle function
* inflammation
* soreness following a marathon run.

Participants will either consume a spray-dried tart cherry supplement or a calorie-matched placebo-control for 7 days, and complete a marathon. Participants will perform functional tests, be assessed for their perceptual recovery and markers of inflammation and muscle damage via:

* maximal voluntary contractions
* counter movement jumps
* visual analog scales to assess soreness
* blood samples

Conditions

  • Exercise Recovery

Interventions

DIETARY_SUPPLEMENT

Tart Cherry

7 day supplementation

OTHER

Placebo

7 day supplementation

Sponsors & Collaborators

  • Iprona Lana SpA

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Principal Investigators

  • Glyn Howatson · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-10-11
Completion
2023-10-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06332222 on ClinicalTrials.gov